Abstract: A solar mounting system stored within a shipping container prior to deployment and wherein the mounting system includes: laterally extending beams that extend outwardly from the top of the shipping container; support mounts connected to the laterally extending beams at positions over the top of the shipping container and at the ends of the laterally extending beams; a first set of higher longitudinal beams spanning between the support mounts; a second set of lower longitudinal beams spanning between ends of the laterally extending beams at positions beside the shipping container; a plurality of PV module support rails extending between the first and second sets of longitudinal beams; and PV modules mounted onto the PV module support rails such that the PV modules slope downwardly from above the center to beyond the sides of the shipping container.

Abstract: A solar mounting system stored within a shipping container prior to deployment and wherein the mounting system includes: laterally extending beams that extend outwardly from the top of the shipping container; support mounts connected to the laterally extending beams at positions over the top of the shipping container and at the ends of the laterally extending beams; a first set of higher longitudinal beams spanning between the support mounts; a second set of lower longitudinal beams spanning between ends of the laterally extending beams at positions beside the shipping container; a plurality of PV module support rails extending between the first and second sets of longitudinal beams; and PV modules mounted onto the PV module support rails such that the PV modules slope downwardly from above the center to beyond the sides of the shipping container.

Abstract: A composition includes particles including at least about 95 wt % of amphotericin B, wherein the particles have a mass median diameter ranging from about 1.1 ?m to about 1.9 ?m. Another composition also includes particles including at least about 95 wt % of amphotericin B, wherein at least about 80 wt % of the particles have a geometric diameter ranging from about 1.1 ?m to about 1.9 ?m. Yet another composition includes particles including amphotericin B, wherein the particles have a mass median diameter less than about 1.9 ?m, and wherein the amphotericin B has a crystallinity level of at least about 20%. Unit dosage forms, delivery systems, and methods may involve similar compositions.

Abstract: The present invention comprises compositions and formulations comprising amphotericin B, compositions and formulations comprising amphotericin B with one or more excipients, methods of making amphotericin B compositions and formulations, as well as systems for using amphotericin B compositions and formulations. Also provided are pharmaceutical compositions comprising the formulation, methods of administering the pharmaceutical compositions and methods of treating patients with the pharmaceutical compositions.

Abstract: A composition includes particles including at least about 95 wt % of amphotericin B, wherein the particles have a mass median diameter ranging from about 1.1 ?m to about 1.9 ?m. Another composition also includes particles including at least about 95 wt % of amphotericin B, wherein at least about 80 wt % of the particles have a geometric diameter ranging from about 1.1 ?m to about 1.9 ?m. Yet another composition includes particles including amphotericin B, wherein the particles have a mass median diameter less than about 1.9 ?m, and wherein the amphotericin B has a crystallinity level of at least about 20%. Unit dosage forms, delivery systems, and methods may involve similar compositions.